Interleukin-1-induced IL-8 and IL-6 gene expression and production in human mesangial cells is differentially regulated by cAMP

Kidney International
R L RobsonZ Brown

Abstract

We have previously proposed that activated mesangial cells (MC) have a direct role in the initiation and propagation of inflammatory events within the glomerulus via the generation of the mesangioproliferative cytokine IL-6 and the chemokines IL-8 and MCP-1. The objective of this study was to investigate the role of cAMP in the regulation of IL-6 and IL-8 gene expression and peptide production in IL-1 stimulated human MC. Agents known to elevate cAMP, including dibutyryl cAMP (db-cAMP), forskolin or isobutyl-methylxanthine (IBMX) were alone unable to induce IL-6 or IL-8 expression or production above media control levels, indicating activation of the cAMP pathway could not mimic IL-1 signaling events. In the presence of IL-1, all three agents produced a marked potentiation of IL-6 mRNA expression and dose-dependent increase in IL-6 peptide production (twofold), but had little or no effect on IL-8 mRNA expression or peptide generation. In marked contrast cholera toxin (CT) caused a dose-dependent potentiation of both IL-1-induced IL-6 (approximately fourfold) and IL-8 peptide (approximately twofold) generation. The control agent, the purified binding subunit of cholera toxin (CT-B) which is devoid of ADP-ribosylating activity al...Continue Reading

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D M Gill, R Meren
Sep 1, 1992·The Journal of Experimental Medicine·D J KesslerG E Sonenshein
Mar 1, 1992·Kidney International·J R SedorM Konieczkowski
Aug 1, 1991·The Journal of Pharmacy and Pharmacology·Y S TaktakS Poole
Jan 1, 1991·Advances in Experimental Medicine and Biology·Z BrownJ Westwick
Nov 1, 1990·Immunology Today·L A O'NeillJ Saklatvala
Jan 1, 1990·Cellular Signalling·S E Schlegel-Haueter, F Aebischer
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J B ImbodenJ D Stobo
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A RayP B Sehgal
Jan 1, 1988·Methods in Enzymology·J J Mekalanos
Oct 1, 1987·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D Schlondorff
May 1, 1993·Current Opinion in Nephrology and Hypertension·J Floege, R J Johnson
Nov 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D M KrepsM L Toews
Dec 17, 1962·Biochimica Et Biophysica Acta·T POSTERNAKW F HENION

❮ Previous
Next ❯

Citations

Jan 28, 1999·American Journal of Respiratory Cell and Molecular Biology·M FuhrmannN Suttorp
Mar 1, 1997·Expert Opinion on Investigational Drugs·K J KallenS Rose-John
Aug 13, 2013·PLoS Pathogens·Mario M ZaissNicola L Harris
Oct 12, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Dan D HershkoPer-Olof Hasselgren
Feb 28, 2009·European Journal of Immunology·Neil E Humphreys, Richard K Grencis
Feb 8, 2020·International Journal of Molecular Sciences·Tian-Yu Lin, Yu-Hsiang Hsu
May 7, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Regiane Costa de OliveiraAndriy Grafov
Jan 25, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·L L ReznikovC A Dinarello
Jul 15, 1999·Journal of the American Society of Nephrology : JASN·C GrasslU Dendorfer
Nov 30, 1999·Journal of the American Society of Nephrology : JASN·B BanasD Schlöndorff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.